Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
Liver dysfunction in a patient with anthracycline-resistant breast cancer and liver metastases with poor performance status (PS) represents a serious situation. Taxanes are the drugs of choice, but once the transaminase enzyme levels are raised more than 10-times the upper limit of normal (>10 UL...
Saved in:
| Main Author: | Ajay Gupta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2012-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2012;volume=33;issue=3;spage=170;epage=172;aulast=Gupta |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival
by: Marieke Schmidt, et al.
Published: (2024-12-01) -
Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose
by: Satoshi Shinozaki, et al.
Published: (2025-02-01) -
Left Ventricular Diastolic Dysfunction in Liver Cirrhotic Patients: Proportion, Correlation, and Relationship of Diastolic Parameters with Stage of Liver Dysfunction
by: Prionggo Mondrowinduro, et al.
Published: (2018-03-01) -
Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma
by: Wenjie Liu, et al.
Published: (2025-04-01) -
Bavachin enhances paclitaxel sensitivity in ovarian cancer cells through modulation of mitochondrial function and ER stress
by: Sang-Jin Lee, et al.
Published: (2025-12-01)